Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device

Completed · Phase 2

Conditions studied: Rheumatoid Arthritis (RA)

In brief

The purpose of this study is to assess the usability of the VIBEX MTX device for SC self-injection of methotrexate.

Key facts

Study ID

NCT01618955

Run by

Antares Pharma Inc.

People needed

101

Starts

2012-05-01

Expected to finish

2012-07-01

Last updated by the study team

2014-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients >18 years of age, diagnosed with Rheumatoid Arthritis

You may not qualify if…

• Pregnant females
• Any other clinically significant disease or disorder which, in the opinion of the investigator might put the subject at risk

Where it is running

• Altoona Center for Clinical Research — Duncansville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.